DalsnaFinance

Avita Medical Inc $RCEL

Health Care

California
Create a scorecard
$13.80
+0.66 (+5.02%)
As of Oct 20, 2026, 5:56 PM EDT · cached
Price history
Loading chart…

Avita Medical Inc (RCEL) is trading up at $13.80 (+5.02%), as of the latest quote. It operates in the Health Care sector.

Avita Medical Inc revenue & net income history (FY2018–FY2025)

RevenueNet incomeNet margin (right axis, %)
$71.6M$4.88M−$61.8MFY2018 revenue: $929.0KFY2018 net income: −$12.7M · Net margin −1370.8%'18FY2019 revenue: $5.47MFY2019 net income: −$25.1M · Net margin −458.6%'19FY2020 revenue: $14.3MFY2020 net income: −$42.0M · Net margin −294.7%'20FY2021 revenue: $29.2MFY2021 net income: −$26.6M · Net margin −90.9%'21FY2022 revenue: $34.4MFY2022 net income: −$26.7M · Net margin −77.5%'22FY2023 revenue: $50.1MFY2023 net income: −$35.4M · Net margin −70.6%'23FY2024 revenue: $64.3MFY2024 net income: −$61.8M · Net margin −96.3%'24FY2025 revenue: $71.6MFY2025 net income: −$48.6M · Net margin −67.8%'25−100%−50%0%50%FY2018 net margin: −1370.8% (off the scale, which stops at −100.0%)FY2019 net margin: −458.6% (off the scale, which stops at −100.0%)FY2020 net margin: −294.7% (off the scale, which stops at −100.0%)FY2021 net margin: −90.9%FY2022 net margin: −77.5%FY2023 net margin: −70.6%FY2024 net margin: −96.3%FY2025 net margin: −67.8%
Avita Medical Inc annual financial statements
FY2018Jun 2018FY2019Jun 2019FY2020Jun 2020FY2021Jun 2021FY2022Dec 2022FY2023Dec 2023FY2024Dec 2024FY2025Dec 2025
Income statement
Revenue$929.0K$5.47M$14.3M$29.2M$34.4M$50.1M$64.3M$71.6M
Growth (year over year)—+489.2%+160.6%+104.9%+17.8%+45.7%+28.1%+11.5%
Gross profit$383.0K$4.20M$11.3M$23.3M$28.4M$42.4M$55.2M$58.8M
Gross margin41.2%76.8%79.2%79.6%82.4%84.5%85.8%82.1%
Operating income−$13.8M−$25.5M−$42.7M−$26.5M−$27.5M−$42.7M−$56.6M−$42.5M
Operating margin−1489.9%−466.4%−299.2%−90.8%−79.9%−85.1%−88.1%−59.4%
Net income−$12.7M−$25.1M−$42.0M−$26.6M−$26.7M−$35.4M−$61.8M−$48.6M
Net margin−1370.8%−458.6%−294.7%−90.9%−77.5%−70.6%−96.3%−67.8%
EPS (diluted)$1.37$1.56$2.07$1.17$1.07−$1.40−$2.39−$1.74
Balance sheet
Cash and equivalents$11.0M$20.2M$73.6M$110.7M$18.2M$22.1M$14.1M$10.2M
Total assets—$25.8M$82.5M$125.5M$98.3M$111.6M$79.7M$56.4M
Total liabilities—$4.95M$10.1M$9.85M$13.0M$61.9M$75.0M$73.0M
Long-term debt—————$39.8M$42.2M$0
Shareholders' equity$14.0M$20.8M$72.4M$115.7M$84.7M$49.1M$4.50M−$16.6M
Cash flow
Operating cash flow−$13.0M−$19.3M−$22.7M−$25.9M−$19.1M−$38.0M−$48.9M−$31.2M
Capital expenditure$365.0K$1.02M$590.0K$894.0K$452.0K$1.38M$9.17M$1.00M
Free cash flow−$13.3M−$20.3M−$23.3M−$26.8M−$19.5M−$39.4M−$58.1M−$32.2M

From Avita Medical Inc's 10-K, 10-KT and 10-Q filings with the SEC; its fiscal year ends in December. Each period shows the latest figure the company has reported for it, including restatements. Net margin is our own calculation from those reported figures (net income ÷ revenue); it is left blank where revenue is zero or missing. † Quarter derived from the company's year-to-date or full-year totals. Filings on SEC EDGAR →

About Avita Medical Inc

Headquarters
Valencia, California From SEC filings, Oct 2026

Recent News (3)

More Health Care stocks

Browse all companies →